Neuro

InspireMD’s CGuard Carotid Embolic Prevention System Featured in Live Case at Cracow Vascular Summit 2017 in Poland

TEL AVIV, ISRAEL — (Marketwired) — Oct 25, 2017 — InspireMD (NYSE MKT:NSPR) (NYSE MKT: NSPR.WS) (NYSE American: NSPR) (NYSE American: NSPR.WS), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that Prof. Waclaw Kuczmik, Head of the Vascular Surgery Department of Katowice Clinical Hospital N […]

Sub-Lite-Wall® StreamLiner™ Series Poised to Become New Design Standard for Improved Access in Catheter Delivery

ORANGEBURG, S.C., Oct. 24, 2017 /PRNewswire/ — Zeus Industrial Products Inc. (“Zeus”) has released its latest thin-walled PTFE catheter liner as part of their Sub-Lite-Wall® StreamLiner™ series. StreamLiner™ XT, the first offering from the series, was released in July with an impressive maximum wall thickness of 0.00075″ (0.01905 mm). The next in the series, […]

InspireMD Announces The Start Of Patient Enrollment In An Investigator Initiated Trial Of Cguard EPS In Russia

TEL AVIV, ISRAEL–(Marketwired – October 09, 2017) – InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR), a leader in Embolic Prevention Systems (EPS) / thrombus management technologies and neurovascular devices, today announced the start of patient enrollment in an investigator initiated trial in Russia, entitled: Independent Randomized Trial in Carotid Artery Revascularization Comparing […]

Flowonix And Cerebral Therapeutics Announce Fifth Implant Of First-Of-A-Kind Implantable Drug Therapy To Treat Patients With Refractory Epilepsy

MOUNT OLIVE, N.J., Oct. 2, 2017 /PRNewswire/ — Flowonix Medical, Inc. and Cerebral Therapeutics, Inc. announced today the successful implant of the fifth patient in the ADDRESS (Australian Direct Drug Administration for Refractory Epilepsy) trial.  The jointly developed therapy features a micro-infusion device which tightly controls drug delivery to a region of the […]

MicroVention Celebrates Grand Opening Of New Worldwide Innovation Center In Aliso Viejo, California

ALISO VIEJO, Calif., Sept. 26, 2017 /PRNewswire/ — MicroVention, a wholly owned subsidiary of Terumo Corporation and a global neurovascular company, today announced that the Grand Opening of its New Innovation Center was held on Monday, September 25. The opening of the new facility, located in the heart of the Summit Office Campus, also […]

InspireMD Announces Distribution Agreement For CGuard EPS In Portugal

TEL AVIV, ISRAEL–(Marketwired – September 21, 2017) – InspireMD, Inc. (NYSE MKT: NSPR) (NYSE American: NSPR) (NYSE MKT: NSPR.WS) (NYSE American: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with Medicinália Cormédica MC Medical Lda, a […]

IMRIS’ Annual Sales Grow Nearly 50% After Bankruptcy Sale

MINNETONKA, Minn., Sept. 12, 2017 /PRNewswire/ — IMRIS, the global leader in intraoperative imaging, recently celebrated its two-year anniversary under new ownership with strong financial growth and strategic investments for continued future success. Through a reorganization and the backing of parent company Deerfield Management in August 2015, IMRIS emerged under a new LLC, brand, […]

Cerus Endovascular Provides Corporate Update

FREMONT, Calif. and OXFORD, England, Sept. 7, 2017 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company engaged in the design and development of highly differentiated and proprietary interventional neuroradiology devices and delivery systems for the treatment of acute, life-threatening neurological conditions, specifically, intracranial aneurysm, today provided an update on its lead development […]

Johnson & Johnson Medical Devices Companies Signals Commitment to Stroke Treatment With the Announcement of New Neurovascular Business

NICE, France, September 7, 2017 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* today introduced CERENOVUS,** its new neurovascular business, at the European Society of Minimally Invasive Neurological Therapy (ESMINT) 9th Annual Meeting. CERENOVUS, a name derived from the Latin words for ‘new’ and ‘brain’, will focus on delivering innovative therapies for hemorrhagic […]